GP-Act III Acquisition Corp.
Price Action
Technical Summary
STAGE 2 UPTRENDGP-Act III Acquisition Corp. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 54), indicating performance broadly in line with the market. Earnings contraction of 26% provides fundamental context to the price action. Momentum will need to be maintained above the 50-day moving average to sustain this leadership phase.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $10.97 | +0.88% | ABOVE |
| 50 SMA | $10.90 | +1.60% | ABOVE |
| 100 SMA | $10.85 | +2.06% | ABOVE |
| 150 SMA | $10.80 | +2.54% | ABOVE |
| 200 SMA | $10.75 | +2.93% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is GPAT in an uptrend right now?
GPAT has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, GPAT is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is GPAT overbought or oversold?
GPAT's RSI (14) is 48. The stock is in neutral territory, neither overbought nor oversold.
Is GPAT outperforming the market?
GPAT has a Relative Strength (RS) Rating of 54 out of 99. GPAT is performing about average compared to the market.
Where is GPAT in its 52-week range?
GPAT is trading at $11.07, which is 92% of its 52-week high ($12.00) and 38% above its 52-week low ($10.50).
How volatile is GPAT?
GPAT has a Beta of -0.00 and 52-week volatility of 8%. It's less volatile than the S&P 500 - generally more stable.